SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-24-164555
Filing Date
2024-06-20
Accepted
2024-06-20 17:06:01
Documents
13
Period of Report
2024-06-20
Items
Item 5.07: Submission of Matters to a Vote of Security Holders

Document Format Files

Seq Description Document Type Size
1 8-K d645924d8k.htm   iXBRL 8-K 34682
  Complete submission text file 0001193125-24-164555.txt   152046

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA agio-20240620.xsd EX-101.SCH 2490
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE agio-20240620_lab.xml EX-101.LAB 17203
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE agio-20240620_pre.xml EX-101.PRE 10775
16 EXTRACTED XBRL INSTANCE DOCUMENT d645924d8k_htm.xml XML 3596
Mailing Address 88 SIDNEY STREET CAMBRIDGE MA 02139
Business Address 88 SIDNEY STREET CAMBRIDGE MA 02139 617-649-8600
AGIOS PHARMACEUTICALS, INC. (Filer) CIK: 0001439222 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36014 | Film No.: 241057361
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)